fig3
Figure 3. Suggested HCC surveillance pathway for patients with NAFLD. HCC: Hepatocellular carcinoma; AGA: American Gastroenterology Association; AFP alpha-fetoprotein; MRI: magnetic resonance imaging; CT: computerized tomography.
Figure 3. Suggested HCC surveillance pathway for patients with NAFLD. HCC: Hepatocellular carcinoma; AGA: American Gastroenterology Association; AFP alpha-fetoprotein; MRI: magnetic resonance imaging; CT: computerized tomography.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/